Clinical trial
Evaluation of Remnant Cholesterol Levels and Monocyte-to-HDL-cholesterol Ratio as Predictors of Coronary Artery Disease Severity in Patients With Acute Coronary Syndrome
NCT06757777 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Remnant Cholesterol Levels and Monocyte-to-HDL-cholesterol Ratio as Predictors of Coronary Artery Disease Severity in Patients With Acute Coronary Syndrome
- Lead sponsor
- Assiut University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- February 8, 2025
- Completion date
- March 8, 2026
- Enrollment
- 54 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
acs (acute coronary syndrome), acute coronary syndrome, monocyte to hdl cholesterol ratio, non stemi, stemi